New patent for Glaxosmithkline drug ARNUITY ELLIPTABy DrugPatentWatch – Make Better Decisions / April 11, 2024 Annual Drug Patent Expirations for ARNUITY+ELLIPTA Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are six patents…Source